0001323885-22-000047.txt : 20220413 0001323885-22-000047.hdr.sgml : 20220413 20220413161228 ACCESSION NUMBER: 0001323885-22-000047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220412 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220413 DATE AS OF CHANGE: 20220413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AtriCure, Inc. CENTRAL INDEX KEY: 0001323885 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 341940305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51470 FILM NUMBER: 22824826 BUSINESS ADDRESS: STREET 1: 7555 INNOVATION WAY CITY: MASON STATE: OH ZIP: 45040 BUSINESS PHONE: 513-755-4100 MAIL ADDRESS: STREET 1: 7555 INNOVATION WAY CITY: MASON STATE: OH ZIP: 45040 8-K 1 atrc-20220412.htm 8-K atrc-20220412
0001323885False00013238852022-04-122022-04-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 12, 2022
AtriCure, Inc.
(Exact name of registrant as specified in charter)
Delaware
000-51470
34-1940305
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer Identification No.)
7555 Innovation Way, Mason OH 45040
(Address of Principal Executive Offices, and Zip Code)
(513) 755-4100
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.001 par valueATRCNASDAQ
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 7.01.    Regulation FD Disclosure.
On April 12, 2022, AtriCure, Inc. (“AtriCure” or the “Company”) issued a press release announcing its launch of the EnCompass Clamp®, a part of the Isolator Synergy™ Ablation System in the United States. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Information in the press release contains forward-looking statements regarding future events and performance of the Company. All such forward-looking statements are based largely on the Company’s experience and perception of current conditions, trends, expected future developments and other factors, and on management’s expectations, and are subject to risks and uncertainties that could cause actual results to differ materially, including, but not limited to, any factors described in the press release and in the Company’s filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise.
The information in this Item 7.01 of this Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Item 7.01 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing (whether made before or after the date hereof) or any other document under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing or document.
Item 9.01    Financial Statements and Exhibits.
(d)Exhibits
No.Description
99.1
104Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ATRICURE, INC.
Dated:April 13, 2022By:/s/ Angela L. Wirick
Angela L. Wirick
Chief Financial Officer

 EX-99.1 2 atrc-20220412xexx991.htm EX-99.1 Document

image_0.jpg
Exhibit 99.1

For immediate release    
April 12, 2022



AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System

New clamp is designed to improve efficiency of concomitant ablation procedures

MASON, Ohio – (BUSINESS WIRE) – April 12, 2022 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has launched the EnCompass Clamp®, a part of the Isolator Synergy™ Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient.
The EnCompass Clamp includes features such as parallel closure, uniform pressure, and custom power using Synergy radiofrequency (RF). The new features of the EnCompass Clamp allow for easier placement using a magnetic guide, which enables more efficient procedures by minimizing tissue dissection.
“The EnCompass Clamp provides a simpler and faster approach to ablating the heart in open-chest procedures,” said Michael Carrel, President and Chief Executive Officer of AtriCure. “We are passionate about innovation, leading to high-quality options for our physician partners. We believe the EnCompass Clamp will meet the unique needs of surgeons who are performing closed-atrium cardiac surgery.”
“This new device has become an invaluable part of the way I perform surgical ablation,” said Dr. Prem Samuel, a cardiothoracic surgeon at Midwest Heart & Vascular Specialists, Kansas City, Missouri. “It is used with minimal dissection and creates lesions around the pulmonary veins and the entire posterior wall of the left atrium without opening the atrium, all in a single pass through the transverse and oblique sinuses. I’ve seen firsthand the gains in efficiency that the EnCompass Clamp can bring to my practice and patients.”

About AtriCure, Inc.
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

CONTACTS:
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
awirick@atricure.com




Valerie Storch-Willhaus
AtriCure, Inc.
Vice President, Corporate Marketing and Communications
(612) 605-3311
vstorch-willhaus@atricure.com



 EX-101.SCH 3 atrc-20220412.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 atrc-20220412_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 atrc-20220412_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0.jpg begin 644 image_0.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Apr. 12, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 12, 2022
Entity Registrant Name AtriCure, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 000-51470
Entity Tax Identification Number 34-1940305
Entity Address, Address Line One 7555 Innovation Way
Entity Address, City or Town Mason
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45040
City Area Code 513
Local Phone Number 755-4100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.001 par value
Trading Symbol ATRC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Central Index Key 0001323885
Amendment Flag false
XML 8 atrc-20220412_htm.xml IDEA: XBRL DOCUMENT 0001323885 2022-04-12 2022-04-12 0001323885 false 8-K 2022-04-12 AtriCure, Inc. DE 000-51470 34-1940305 7555 Innovation Way Mason OH 45040 513 755-4100 false false false false Common Stock, $.001 par value ATRC NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.atricure.com/role/Cover Cover Cover 1 false false All Reports Book All Reports atrc-20220412.htm atrc-20220412.xsd atrc-20220412_lab.xml atrc-20220412_pre.xml atrc-20220412xexx991.htm http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "atrc-20220412.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "atrc-20220412.htm" ] }, "labelLink": { "local": [ "atrc-20220412_lab.xml" ] }, "presentationLink": { "local": [ "atrc-20220412_pre.xml" ] }, "schema": { "local": [ "atrc-20220412.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "atrc", "nsuri": "http://www.atricure.com/20220412", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "atrc-20220412.htm", "contextRef": "ia7e335f44633433699de433a5ddb0c3c_D20220412-20220412", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.atricure.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "atrc-20220412.htm", "contextRef": "ia7e335f44633433699de433a5ddb0c3c_D20220412-20220412", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001323885-22-000047-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001323885-22-000047-xbrl.zip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